Common Contracts

AMENDMENT N0 1 TO THE PATENT LICENSE AGREEMENT n° C-00061905

Patent License Agreement • March 12th, 2019 • Cellectis S.A. • Biological products, (no disgnostic substances)

• Contract Type
  Patent License Agreement
• Filed
  March 12th, 2019
• Company
  Cellectis S.A.
• Industry
  Biological products, (no disgnostic substances)

Public limited company with capital with a capital of 122,363.47 euros, with its registered office at at 28, rue du Docteur Roux, 75724 Paris cedex 15, represented by Mr. André Choulika, acting in the capacity of CEO

AMENDMENT NO 1 TO THE PATENT LICENSE AGREEMENT n° C-00061905

Patent License Agreement • March 12th, 2015 • Cellectis S.A. • Biological products, (no disgnostic substances)

• Contract Type
  Patent License Agreement
• Filed
  March 12th, 2015
• Company
  Cellectis S.A.
• Industry
  Biological products, (no disgnostic substances)

IP filed two provisional patents applications in the United States whom inventors are Mr. Richard Mulligan and Mr. André Choulika relating to process of homologous recombination using meganucleases. IP has agreed to share with BCH exploitation rights of the inventions of theses patent applications and now wishes to share its rights under this technology with a industrial partner.